AUSTIN, TX / ACCESS Newswire / February 5, 2025 / Volcon, Inc. (NASDAQ:VLCN) (the "Company"), the first all-electric, off-road ...

Volcon (VLCN) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the company expected to be ...

Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...

CERo Therapeutics (CERO) announced the pricing of its “reasonable best efforts” public offering with participation from a ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), a company engaged in developing drug delivery systems for pain management, announced the pricing of its public offering at $0.20 per share of ...

The Capital Market Authority (CMA) approved Saudi Economic and Development Securities Co.’s (SEDCO) request for the public ...

today announced the pricing of a best-efforts public offering of 762,500 common shares at a public offering price of $4.00 per share. Total gross proceeds from the offering, before deducting ...

In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.

Akero Therapeutics announced a public offering of over 5.3 million shares at $48 each, aiming for $350 million in proceeds. Akero Therapeutics, Inc. has announced a public offering of 5,333,420 ...

Investing.com -- Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company ...